Yesterday, Dec. 10, 2015, 74 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $42,564,049.20.

Highlighted Stocks Traded by Insiders:

OFG Bancorp (OFG) - FREE Research Report

Kumar Ganesh, who is Cfo & Evp at OFG Bancorp, sold 3,311 shares at $17.08 on Dec. 10, 2015. Following this transaction, the Cfo & Evp owned 39 shares meaning that the stake was reduced by 98.84% with the 3,311-share transaction.

The shares most recently traded at $6.73, down $10.35, or 153.8% since the insider transaction. Historical insider transactions for OFG Bancorp go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 6,829
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 6,829
  • 24-Week # shares bought: 8,600
  • 24-Week # shares sold: 31,829

The average volume for OFG Bancorp has been 648,300 shares per day over the past 30 days. OFG Bancorp has a market cap of $298.3 million and is part of the financial sector and banking industry. Shares are down 58.44% year-to-date as of the close of trading on Thursday.

OFG Bancorp, a financial holding company, provides various banking and financial services primarily in Puerto Rico. It operates in three segments: Banking, Wealth Management, and Treasury. The stock currently has a dividend yield of 3.53%. The company has a P/E ratio of 75.6. Currently, there are 2 analysts who rate OFG Bancorp a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on OFG - FREE

TheStreet Quant Ratings rates OFG Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, feeble growth in the company's earnings per share and deteriorating net income. Get the full OFG Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Usana Health (USNA) - FREE Research Report

Gull Global Ltd, who is 10% Owner at Usana Health, sold 10,000 shares at $133.18 on Dec. 10, 2015. Following this transaction, the 10% Owner owned 6.4 million shares meaning that the stake was reduced by 0.16% with the 10,000-share transaction.

The shares most recently traded at $128.39, down $4.79, or 3.73% since the insider transaction. Historical insider transactions for Usana Health go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 20,000
  • 24-Week # shares sold: 41,000

The average volume for Usana Health has been 132,000 shares per day over the past 30 days. Usana Health has a market cap of $1.7 billion and is part of the health care sector and drugs industry. Shares are up 26.99% year-to-date as of the close of trading on Thursday.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease worldwide. The company has a P/E ratio of 18.9. Currently, there is 1 analyst who rates Usana Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on USNA - FREE

TheStreet Quant Ratings rates Usana Health as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Usana Health Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Diamondback Energy (FANG) - FREE Research Report

Wexford Capital Lp, who is Director at Diamondback Energy, sold 9,822 shares at $76.74 on Dec. 10, 2015. Following this transaction, the Director owned 67,232 shares meaning that the stake was reduced by 12.75% with the 9,822-share transaction.

The shares most recently traded at $77.40, up $0.66, or 0.86% since the insider transaction. Historical insider transactions for Diamondback Energy go as follows:

  • 4-Week # shares sold: 4,285
  • 12-Week # shares sold: 9,915
  • 24-Week # shares sold: 9,915

The average volume for Diamondback Energy has been 1.1 million shares per day over the past 30 days. Diamondback Energy has a market cap of $5.1 billion and is part of the basic materials sector and energy industry. Shares are up 32.3% year-to-date as of the close of trading on Thursday.

Diamondback Energy, Inc., an independent oil and natural gas company, focuses on the acquisition, development, exploration, and exploitation of onshore oil and natural gas reserves in the Permian Basin in West Texas. Currently, there are 15 analysts who rate Diamondback Energy a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FANG - FREE

TheStreet Quant Ratings rates Diamondback Energy as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Diamondback Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.